Bionomics Limited (Bionomics)

Oncology Corporate Profile

HQ Location

31 Dalgleish Street
Thebarton SA 5031, Australia

Company Description

Bionomics is an Australian based international biotechnology company which discovers and develops innovative therapeutics for cancer and diseases of the central nervous system. Bionomics has small molecule and antibody product development programs in the areas of cancer, anxiety, and memory loss. Its oncology approach includes cancer stem cell therapeutics as well as vascular disruption in solid tumors.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BNC-105vascular disrupting agent (VDA)MesotheliomaII
BNC-105vascular disrupting agent (VDA)Ovarian cancerII
BNC-105vascular disrupting agent (VDA)Renal cell carcinoma (RCC)II
BNC-105vascular disrupting agent (VDA)Various cancer typesII
BNC-102multispecific antibodyVarious cancer typesDevelopment
BNC-101monoclonal antibodyVarious cancer typesPreclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display